PlainRecalls
FDA Drug Critical Class I Terminated

Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.

Reported: March 23, 2022 Initiated: February 9, 2022 #D-0725-2022

Product Description

Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.

Reason for Recall

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Details

Recalling Firm
Walmart Stores
Units Affected
unknown
Distribution
Nationwide in the USA via www.walmart.com
Location
Bentonville, AR

Frequently Asked Questions

What product was recalled?
Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.. Recalled by Walmart Stores. Units affected: unknown.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 23, 2022. Severity: Critical. Recall number: D-0725-2022.